XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Mar. 31, 2022
Current Assets    
Cash and cash equivalents $ 4,378,668 $ 6,106,827
Accounts receivable 4,677 2,596
Inventory, net 180,874 98,313
Prepaid expenses and other assets 504,819 547,664
Total Current Assets 5,069,038 6,755,400
Property and Equipment, net 311,120 311,549
Other Assets:    
Operating lease right-of-use 284,344 299,101
Patents and trademarks, net 46,225 48,452
Security deposit 12,830 12,830
Total Other Assets 343,399 360,383
Total Assets 5,723,557 7,427,332
Current Liabilities    
Accounts payable 477,947 323,384
Accrued expenses 676,554 784,375
Operating lease liability – short term 59,492 59,178
Note payable and accrued interest 6,639 6,549
Total Current Liabilities 1,220,632 1,173,486
Other Liabilities    
Note payable and accrued interest (net of current portion) 25,548 27,201
Operating lease liability (net of current portion) 224,852 239,923
Total Other Liabilities 250,400 267,124
Total Liabilities 1,471,032 1,440,610
Commitments and Contingencies (see Note 9)
Stockholders’ Equity:    
Preferred stock, par value $0.001, 20,000,000 shares authorized, 0 and 0 shares issued and outstanding at June 30, 2022 and March 31, 2022
Common stock, par value $0.001, 250,000,000 shares authorized, 9,988,361 shares issued and outstanding at June 30, 2022 and March 31, 2022, respectively 9,988 9,988
Additional Paid-In Capital 69,334,386 69,103,155
Accumulated Deficit (65,091,849) (63,126,421)
Total Stockholders’ Equity 4,252,525 5,986,722
Total Liabilities and Stockholders’ Equity $ 5,723,557 $ 7,427,332